Muscarinic receptor-mediated activation of nitric oxide synthase

Drug Development Research

Volumn 40, Issue 2, 1997, Pages 205-214

  Wotta, Diane R ^a   El Fakahany, Esam E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Muscarinic acetylcholine receptors; Nitric oxide; Second messengers

Indexed keywords

MUSCARINIC RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

BRAIN; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; NEUROTRANSMITTER RELEASE; NONHUMAN; RECEPTOR BINDING; REVIEW; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE;

EID: 0030983429     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199702)40:2<205::AID-DDR10>3.0.CO;2-K     Document Type: Review

References (88)

1. Amar S, Kitabgi P, Vincent J-P (1987): Stimulation of inositol phosphate production by neurotensin in neuroblastoma N1E-115 cells: Implication of GTP-binding proteins and relationship with the cyclic CMP response. J Neurochem 49:999-1006.
2. Aoki E, Takeuchi IK, Shoji R (1995): Nitric oxide: An attractive signaling molecule. Acta Histochem Cytochem 28:97-106.
3. Arroyo CM, Forray C, El-Fakahany EE, Rosen GM (1990): Receptor-mediated generation of an EDRF-like intermediate in a neuronnal cell line detected by spin trapping techniques. Biochem Biophys Res Commun 170:1177-1183.
4. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T (1993): Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA 90:347-351.
5. Bredt DS (1995): Molecular characterization of nitric oxide synthase. In Vincent SR (ed): Nitric Oxide in the Nervous System. San Diego: Academic Press, pp 1-19.
6. Bredt DS, Snyder SH (1990): Isolation of nitric oxide synthase, a calm-odulin-requiring enzyme. Proc Natl Acad Sci USA 87:682-685.
7. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH (1991): Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351:714-718.
8. Bredt DS, Ferris CD, Snyder SH (1992): Nitric oxide synthase regulatory sites: Phosphorylation by cyclic AMP dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase: Identification of flavin and calmodulin binding sites. J Biol Chem 267:10976-10981.
9. Brooker G (1977): Dissociation of cyclic GMP from the negative inotropic action of carbachol in guinea pig atria. J Cyclic Nucleotide Res 3:407-413.
10. Castoldi AF, Manzo L, Costa LG (1993): Cyclic GMP formation induced by muscarinic receptors is mediated by nitric oxide synthesis in rat cortical primary cultures. Brain Res 610:57-61.
11. 2+ release and influx responses in PC12-64 cells. Eur J Pharmacol 289:113-123.
12. Dauphin F, Hamel E (1990): Muscarinic receptor subtype mediating vasodilation in feline middle cerebral artery exhibits M3 pharmacology. Eur J Pharmacol 178:203-213.
13. Dauphin F, Hamel E (1992): Identification of multiple muscarinic binding site subtypes in cat and human cerebral vasculature. J Pharmacol Exp Ther 260:660-667.
14. Dauphin F, Linville DG, Hamel E (1994): Cholinergic dilatation and constriction of feline cerebral blood vessels are mediated by stimulation of phosphoinositide metabolism via two different muscarinic receptor subtypes. J Neurochem 63:544-551.
15. Diamond J, Teneick RE, Trapani AJ (1977): Are increases in cGMP levels responsible for the negative inotropic effects of acetylcholine in the heart? Biochem Biophys Res Commun 79:912-918.
16. Dinerman JL, Lowenstein CJ, Snyder SH (1993): Molecular mechanisms of nitric oxide regulation: Potential relevance to cardiovascular disease. Circ Res 73:217-222.
17. Duarte ID, Lorenzetti BB, Ferreira SH (1990): Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur J Pharmacol 186:289-293.
18. Duarte IDG, Dos Santos IR, Lorenzetti BB, Ferreira SH (1992): Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway. Eur J Pharmacol 217:225-227.
19. El-Fakahany EE, Surichamorn W, Amrhein CL, Stenstrom S, Cioffi CL, Richelson E, McKinney M (1988): Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine. J Pharmacol Exp Ther 247:934-940.
20. Forstermann U, Mulsch A, Bohme E, Busse R (1986): Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res 58:531-538.
21. Furchgott RF, Zawadzki JV (1980): The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376.
22. Furchgott RF, Vanhoutte PM (1989): Endothelium-derived relaxing and contracting factors. FASEB J 3:2007-2018.
23. George WJ, Wilkerson RD, Kadowitz PJ (1973): Influence of acetylcholine on contractile force and cyclic nucleotide levels in the isolated perfused rat heart. J Pharmacol Exp Ther 184:228-235.
24. Giles W, Noble SJ (1976): Changes in membrane currents in bullfrog atrium produced by acetylcholine. J Physiol (Lond) 261:103-123.
25. Goy MF (1991): cGMP: The wayward child of the cyclic nucleotide family. Trends Neurosci 74:293-299.
26. Groschner K, Holzmann S, Kukovetz WR (1986): Lack of second messenger function of cyclic GMP in acetylcholine-induced negative inotropism. J Cardiovascular Pharmacol 8:1154-1157.
27. Gukovskaya A, Pandol S (1994): Nitric oxide production regulates cGMP formation and calcium influx in pancreatic acinar cells. Am J Physiol 266:350-356.
28. Hanley MR, Iversen LL (1978): Muscarinic cholinertic receptors in rat corpus struatum and regulation of guanosine cyclic 3′,5′-monophosphate. Mol Pharmaol 14:246-255.
29. Hoffman RA, Langrehr JM, Billiar TR, Curran RD, Simmons RL (1990): Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol 145:2220-2226.
30. Hu J, El-Fakahany EE (1993): Role of intercellular and intracellular communication by nitric oxide in coupling of muscarinic receptors to activation of guanylate cyclase in neuronal cells. J Neurochem 61:578-585.
31. Iadecola C (1993): Regulation of the cerebral microcirculation during neural activity: Is nitric oxide the missing link? Trends Neurosci 16:206-214.
32. Ignarro LJ (1990): Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30:535-560.
33. Ignarro LJ, Degnan JN, Baricos WH, Kadowitz PJ, Wolin MS (1982): Activation of purified guanylate cyclase by nitric oxide requires home: Comparison of the heme-deficient, heme-reconstituted and heme-containing fonns of soluble enzyme from bovine lung. Biochim Biophys Acta 718:49-59.
34. Ignarro LJ, Adams JB, Horwitz PM, Wood KS (1986): Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms. J Biol Chem 261:4997-5002.
35. Ignarro LJ, Byrns RE, Buga GM, Wood KS (1987): Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 61:866-879.
36. Ignarro LJ, Byrns RE, Buga GM, Wood KS, Chaudhuri G (1988): Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation. J Pharmacol Exp Ther 244:181-189.
37. Iwamoto ET, Marion L (1994): Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats. J Pharmacol Exp Ther 269:699-708.
38. Jassens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD (1992): Cloning and expression of a DNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 267:14519-14522.
39. Jope RS, Song L, Kolasa K (1992): Inositol trisphosphate, cyclic AMP, and cyclic GMP in rat brain regions after lithium and seizures. Biol Psychol 31:505-514.
40. Kendall DA (1986): Cyclic GMP formation and inositol phosphate accumulation do not share common origins in rat brain slices. J Neurochem 47:1483-1489.
41. Kilbourn RG, Griffith OW (1992): Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 84:827-831.
42. Kilter H, Lenz O, LaRosee K, Flesch M, Schwinger HG, Madge M, Kuhn-Regnier F, Bohm M (1995): Evidence against a role of nitric oxide in the indirect negative inotropic-effect of M-cholinoceptor stimulation in human ventricular myocardium. Naunyn-Schmiedebergs Arch Pharmacol 352:308-312.
43. Kitto KF, Haley JE, Wilcox GL (1992): Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci Lett 148:1-5.
44. Knowles RG, Palacios M, Palmer RM, Moncada S (1990): Kinetic characteristics of nitric oxide synthase from rat brain. Biochem J 269:207-210.
45. Krause EG, Halle W, Wollenberger A (1972): Effect of dilnityryl cyclic GMP on cultured beating rat heart cells. Adv Cyclic Nucleotide Res 1:301-305.
46. Kuo PC, Schroeder RA (1995): The emerging multifaceted roles of nitric oxide. Ann Surg 221:220-235.
47. Kwon NS, Nathan CF Gilker C, Griffith OW, Matthews DE, Stuehr DJ (1990): L-citrulline production from L-arginine by macrophage nitric oxide synthase. The ureido oxygen derives from dioxygen. J Biol Chem 265:13442-13445.
48. Lamas S, Marsden PA, Li GK, Tempst P, Michel T (1992): Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 89:6348-6352.
49. Lenox RH, Kant GJ, Meyerhoff JL (1980): Regional sensitivity of cyclic AmP and cyclic GMP in rat brain to central cholinergic stimulation. Life Sci 26:2201-2209.
50. Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR (1991): Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 11:3218-3226.
51. Lonart G, Wang J, Johnson KM (1992): Nitric oxide induces neurotransmitter release from hippocampal slices. Eur J Pharmacol 220:271-272.
52. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH (1992): Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 89:6711-6715.
53. Lyons CR, Orloff GJ, Cunningham JM (1992): Molecular cloning and functional expression of an inducible nitric oxide synthase from a nmrine macrophage cell line. J Biol Chem 267:6370-6374.
54. Mayer B (1995): Biochemistry and molecular pharmacology of nitric-oxide synthases. In Vincent SR (ed): Nitric Oxide in the Nervous System. San Diego: Academic Press, pp21-12.
55. MeCartney-Francis N, Allen JN, Mizel DE, Albina J, Xie QW, Nathan CF, Wahl SM (1993): Suppression of arthritis by an inhibitor of nitric-oxide synthase. J Exp Med 178:749-753.
56. McKinney M, Bolden C, Smith C, Johnson A, Richelson E (1990): Selective blockade of receptor-mediated cyclic GMP formation in N1E-115 neuroblastoma cells by an inhibitor of nitric oxide synthesis. Eur J Pharmacol 178:139-140.
57. 1,2. J Pharmacol Exp Ther 257:1121-1129.
58. McMahon TJ, Hood JS, Kadauitz PJ (1992): Pulmonary vasodilator response to vagal stimulation is blocked by N-omega-nitro-L-arginine methylester. Circ Res 70:364-369.
59. Meller ST, Dykstra C, Gebhart GF (1992): Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur J Pharm 214:93-96.
60. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ (1981): Evidence for the inhibitory role of guanosine 3′5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57:946-955.
61. Miller MJS, Sadowska-Krowicka H, Chotinaniemol S, Kakkis JL, Clark DA (1993): Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 264:11-16.
62. Mitchell HH, Shonle HA, Grindley HS (1916): The origin of nitrates in urine. J Biol Chem 24:461-490.
63. Moncada S, Higgs EA (1995): Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9:1319-1330.
64. Montague PR, Gancayco CD, Winn MJ, Marchase RB, Friedlander MJ (1994): Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 263:974-977.
65. Moro V, Badaut J, Springhetti V, Edvinsson L, Seylaz J, Lasbennes F (1995): Regional study of the co-localization of neuronal nitric oxide synthase with muscarinic receptors in the rat cerebral cortex. Neurosci 69:797-805.
66. Nathan C (1992): Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064.
67. Nathan CF Hibbs JB (1991): Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3:65-70.
68. Nathan C, Xie QW (1994a): Nitric oxide synthases: Roles, tolls and controls. Cell 78:915-918.
69. Nathan C, Xie QW (1994b): Regulation of biosynthesis of nitric oxide. J Biol Chem 269:13725-13728.
70. Nawrath H (1977): Does cyclic CMP mediate the negative inotropic effect of acetylcholine in the heart? Nature 267:72-74.
71. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Paakkari I, Lindsberg P (1995): Nitric oxide in the central nervous system. Ann Med 27:369-377.
72. Palmer RMJ (1993): The discovery of nitric oxide in the vessel wall. A unifying concept in the pathogenesis of sepsis. Arch Surg 128:396-401.
73. Palmer RM, Ferrige AG, Moncada S (1987): Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526.
74. Pandol SJ, Schoeffield-Payne MS (1990): Cyclic GMP mediates the agonist-stimulated increase in plasma membrane calcium entry in the pancreatic acinar cell. J Biol Chem 265:12846-12853.
75. Pou WS, Pou S, Rosen GM, El-Fakahany EE (1990): EDRF release is a common pathway in the activation of guanylate cyclase by receptor agonists and calcium ionophores. Eur J Pharmacol 182:393-394.
76. Prast H, Philippu A (1992): Nitric oxide releases acetylcholine in the basal forebrain. Eur J Pharm 216:139-140.
77. Rapoport RM, Murad F (1983): Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP J Cyc Nuc Prot Phos Res 9:281-296.
78. Sandor NT, Brassai A, Puskas A, Lendvai B (1995): Role of nitric oxide in modulating neurotransmitter release from rat striatum. Brain Res Bull 36:483-486.
79. Schmidt HHHW, Walter U (1994): NO at work. Cell 78:919-925.
80. Sessa WC, Harrison JK, Barber CM, Zeng D, Durieux ME, D'Angelo DD, Lynch KR, Peach MJ (1992): Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem 267:15274-15276.
81. 2+ mobilization in muscarinic and histamine receptor-mediated activation of guanylate cyclase in N1E-115 neuroblastoma cells: assessment of the arachidonic acid release hypothesis. Mol Pharmacol 37:860-869.
82. Tracey WR, Peach MJ (1992): Differential muscarinic receptor mRNA expression by freshly isolated and cultured bovine aortic endothelial cells. Circ Res 70:234-240.
83. Vilaro MT, Palacios JM, Mengod G (1990): Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry. Neurosci Lett 114:154-159.
84. Wang SZ, Zhu SZ, El-Fakahany EE (1994): Efficient coupling of m5 muscarinic acetylcholine receptors to activation of nitric oxide synthase. J Pharmacol Exp Ther 268:552-557.
85. Weiner DM, Levey AI, Brann MR (1990): Expression of muscarinic acetylchoine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci USA 87:7050-7054.
86. Xie Q, Nathan C (1994): The high-output nitric oxide pathway: role and regulation. J Leukocyte Biol 56:576-582.
87. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso R, Nathan C (1992): Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228.
88. Zhu XZ, Luo LC (1992): Effect of nitroprusside (Nitric Oxide) on endogenous dopamine release from rat striatal slices. J Neurochem 59:932-935.